Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal ...
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...